Communicated by Iain McIntosh
A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia†
Article first published online: 17 NOV 2011
© 2011 Wiley Periodicals, Inc.
Volume 33, Issue 1, pages 218–231, January 2012
How to Cite
Suleman, F., Gualeni, B., Gregson, H. J., Leighton, M. P., Piróg, K. A., Edwards, S., Holden, P., Boot-Handford, R. P. and Briggs, M. D. (2012), A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia. Hum. Mutat., 33: 218–231. doi: 10.1002/humu.21631
- Issue published online: 14 DEC 2011
- Article first published online: 17 NOV 2011
- Accepted manuscript online: 17 OCT 2011 09:28AM EST
- Manuscript Accepted: 16 SEP 2011
- Manuscript Received: 21 JUL 2011
- Wellcome Trust. Grant Number: Grants 071161/Z/03/Z, 084353/Z/07/Z, and 078456/Z/05/Z
- 2009. The unfolded protein response and its relevance to connective tissue diseases. Cell Tissue Res 339:197–211. , .
- 2002. Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations. Hum Mutat 19:465–478. , .
- 1995. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 10:330–336. , , , , , , , , , , , , .
- 1998. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet 62:311–319. , , , , , , , , , , , , , , .
- 2001. Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet 28:393–396. , , , , , .
- 2005. Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 280:32655–32661. , , , , .
- 1994. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 354:237–240. , , , , .
- 2004. Genetic background has a major effect on the penetrance and severity of craniofacial defects in mice heterozygous for the gene encoding the nucleolar protein Treacle. Dev Dyn 229:907–914. , .
- 2003. Apoptosis staining in cultured pseudoachondroplasia chondrocytes. Apoptosis 8:191–197. , , , , .
- 2010. Defining the mechanism of polymerization in the serpinopathies. Proc Natl Acad Sci USA 107:17146–17151. , , , , , , , , .
- 2005. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum Mol Genet 14:859–871. , , , , , , , , , , , .
- 2007. Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases. J Biol Chem 282:34634–34643. , , , , , , , .
- 2008. Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins. J Biol Chem 283:648–659. , , , .
- 2007. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 282:31166–31173. , , , .
- 2011. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-kappaB signaling. Cancer Lett 307:200–210. , , , .
- 2003. Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis. Am J Pathol 163:101–110. , , , .
- 1998. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol 17:269–278. , , , , , , .
- 2005. COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol 23:525–533. , , , .
- 2001. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes. Matrix Biol 20:251–262. , , , , , , , , , .
- 2004. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate. J Orthop Res 22:759–767. , , , , , , , .
- 1995. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 10:325–329. , , , , , , , , , , .
- 2001. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 276:6046–6055. , , , , , .
- 2011. Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis. Kidney Int 80:959–969. , , , , , , .
- 1998. Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Genet 103:633–638. , , , , , , , , .
- 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249–264. , , , , , , .
- 2008. Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci 49:2956–2963. , , , , , , .
- 2005a. COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia. Eur J Hum Genet 13:547–555. , , , , , , , , .
- 2005b. Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia–multiple epiphyseal dysplasia disease group. Hum Mutat 25:593–594. , , , , , , , , , , .
- 2005. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J Biol Chem 280:16942–16948. , , , , , .
- 2007. Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. Hum Mol Genet 16:1728–1741. , , , , , , , , , , .
- 1999. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 8:35–44. , , , , , .
- 2004. Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 279:25294–25298. , , , , .
- 1959. [Pseudo-achondroplastic forms of spondylo-epiphyseal dysplasias.]. Presse Med 67:383–386. , .
- 1980. The mild form of pseudoachondroplasia. Identity of the morphological and biochemical alterations of growth cartilage with those of typical pseudoachondroplasia. Eur J Pediatr 133:227–231. , , , .
- 1996. The development of articular cartilage: I. The spatial and temporal patterns of collagen types. J Anat 189(Pt 1):9–22. , , , .
- 1996. A mutation in the gene encoding the alpha 2 chain of the fibril- associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nat Genet 12:103–105. , , , , , , , .
- 2001. Modifier genes in mice and humans. Nat Rev Genet 2:165–174.
- 2010. An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia. Cell Stress Chaperones 15:835–849. , , , , , , , , .
- 1992. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 267:22346–22350. , , , .
- 1999. COL9A3: a third locus for multiple epiphyseal dysplasia. Am J Hum Genet 64:1036–1044. , , , , , , .
- 2007. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. Hum Mol Genet 16:2072–2088. , , , , , , , .
- 2009. An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype. Am J Pathol 175:1555–1563. , , , , , , , .
- 2008. Model systems for studying skeletal dysplasias caused by TSP-5/COMP mutations. Cell Mol Life Sci 65:687–699. , , , , .
- 2009. Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLoS Genet 5:e1000691. , , , , , , , , , , , , , .
- 1994. A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix. Hum Genet 93:236–242. , , , , , , , , , , , , , .
- 2010. Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin. Mol Cell Biochem 338:215–224. , , , .
- 1998. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 273:20397–20403. , , , .
- 2003. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains. Cell Mol Life Sci 60:1513–1523. , , , , , .
- 2008. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations. Matrix Biol 27:67–85. , , , , , .
- 2003. Identification of cartilage oligomeric matrix protein (COMP) gene mutations in patients with pseudoachondroplasia and multiple epiphyseal dysplasia. J Hum Genet 48:222–225. , , , , .
- 2002. Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol Cell Biol 22:4366–4371. , , , , , , .
- 2001. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem 276:6083–6092. , , , , , , , .
- 2001. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia. Matrix Biol 20:439–450. , , , , , , , , , .
- 1986. Pseudoachondroplasia: clinical diagnosis at different ages and comparison of autosomal dominant and recessive types. A review of 32 patients (26 kindreds). J Med Genet 23:425–434. , , .
- 2007. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation. J Biol Chem 282:11347–11355. , , , , , , .
- 2011. Peroxiredoxin 2 inhibits granulosa cell apoptosis during follicle atresia through the NFKB pathway in mice. Biol Reprod 84:1182–1189. , , , , , , , , , , , .